Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: J Thromb Thrombolysis. 2013 Feb;35(2):209–222. doi: 10.1007/s11239-012-0812-9

Fig 2.

Fig 2

Top panel residual bivalirudin effects on thrombin-mediated platelet aggregation. Platelet aggregation was measured in platelets pre-treated with varying concentrations of bivalirudin (0–10 μg).F ollowing pre-treatment, platelets were washed either once or twice and resuspended in platelet buffer. Maximal platelet aggregation was measured. Bottom panel comparison of basal levels of PAC-1 and P-selectin before and after treatment with bivalirudin (N = 57; NS)